Search results for "release"

showing 10 items of 602 documents

CMB spectral distortions in generic two-field models

2017

We investigate the CMB $\mu$ distortion in models where two uncorrelated sources contribute to primordial perturbations. We parameterise each source by an amplitude, tilt, running and running of the running. We perform a detailed analysis of the distribution signal as function of the model parameters, highlighting the differences compared to single-source models. As a specific example, we also investigate the mixed inflaton-curvaton scenario. We find that the $\mu$ distortion could efficiently break degeneracies of curvaton parameters especially when combined with future sensitivity of probing the tensor-to-scalar ratio $r$. For example, assuming bounds $\mu < 0.5 \times 10^{-8}$ and $r<0.0…

Cosmology and Nongalactic Astrophysics (astro-ph.CO)Field (physics)ART. NO. 023505Cosmic microwave backgroundFOS: Physical sciencesAstrophysics::Cosmology and Extragalactic Astrophysics114 Physical sciences01 natural sciencesCosmologyHigh Energy Physics - Phenomenology (hep-ph)EARLY UNIVERSEDistortion0103 physical sciencesphysics of the early universeENERGY-RELEASEStatistical physicsSensitivity (control systems)inflation010303 astronomy & astrophysicsPhysicsInflation (cosmology)010308 nuclear & particles physicscosmological parameters from CMBRCURVATURE PERTURBATIONCONSTRAINTSAstronomy and AstrophysicsFunction (mathematics)115 Astronomy Space scienceMIXED INFLATONHigh Energy Physics - PhenomenologyDENSITY PERTURBATIONSAmplitudeCOSMOLOGYRADIATIONAstrophysics - Cosmology and Nongalactic AstrophysicsGENERATIONJournal of Cosmology and Astroparticle Physics
researchProduct

Photometric and Spectroscopic Properties of Type Ia Supernova 2018oh with Early Excess Emission from the $Kepler$ 2 Observations

2019

Supernova (SN) 2018oh (ASASSN-18bt) is the first spectroscopically-confirmed type Ia supernova (SN Ia) observed in the $Kepler$ field. The $Kepler$ data revealed an excess emission in its early light curve, allowing to place interesting constraints on its progenitor system (Dimitriadis et al. 2018, Shappee et al. 2018b). Here, we present extensive optical, ultraviolet, and near-infrared photometry, as well as dense sampling of optical spectra, for this object. SN 2018oh is relatively normal in its photometric evolution, with a rise time of 18.3$\pm$0.3 days and $\Delta$m$_{15}(B)=0.96\pm$0.03 mag, but it seems to have bluer $B - V$ colors. We construct the "uvoir" bolometric light curve hav…

DATA RELEASEULTRAVIOLETFACTORY OBSERVATIONSFOS: Physical sciencesAstrophysicsType (model theory)medicine.disease_causeSN 2011FE01 natural sciencesLuminosityPhotometry (optics)individual (SN 2018oh) [supernovae]supernovae: generalCIRCUMSTELLAR MATERIAL0103 physical sciencesmedicineSPECTRAAbsorption (logic)Ejecta010303 astronomy & astrophysicssupernovae: individualQCSolar and Stellar Astrophysics (astro-ph.SR)QBLIGHT CURVESHigh Energy Astrophysical Phenomena (astro-ph.HE)PhysicsHIGH-VELOCITY FEATURES010308 nuclear & particles physicsAstronomy and AstrophysicsLight curveSupernovaAstrophysics - Solar and Stellar Astrophysics13. Climate actionSpace and Planetary ScienceIMPROVED DISTANCESWHITE-DWARF MODELSAstrophysics - High Energy Astrophysical Phenomena[PHYS.ASTR]Physics [physics]/Astrophysics [astro-ph]general [supernovae]Ultraviolet
researchProduct

Alteration of nuclear (2'-5')oligoriboadenylate synthetase and nuclease activities preceding replication of human immunodeficiency virus in H9 cells.

1988

After infection of the respective target cells with the human immunodeficiency virus (HIV-1) viral progeny is produced only after a short temporary delay of some days, depending on cell type. After this period of time a sudden onset of HIV-1 protein synthesis with a dramatic increase in virus release occurs. (2'-5')Oligoriboadenylates [(2'-5')A], capable to activate a latent ribonuclease (RNase L) degrading both mRNA and rRNA, are known mediators involved in the early response of cells to virus infection. Here we show that the (2'-5')A-synthesizing (2'-5')A synthetase, which is inducible by interferon and activated by double-stranded RNA, as well as a (2'-5')A nuclease (2',3'-exoribonucleas…

DNA ReplicationRNase PNuclear EnvelopeVirus ReplicationBiochemistryVirusCell LineSubstrate SpecificityInterferonExoribonucleaseEndoribonucleasesmedicine2'5'-Oligoadenylate SynthetaseHumansRibonucleaseCell NucleusMessenger RNAbiologyChemistryNucleic Acid HybridizationCell Transformation ViralVirologyMolecular biologyVirus ReleaseKineticsbiology.proteinHIV-1Exoribonuclease activitymedicine.drugBiological chemistry Hoppe-Seyler
researchProduct

Oligonucleotide-capped mesoporous silica nanoparticles as DNA-responsive dye delivery systems for genomic DNA detection

2015

[EN] New hybrid oligonucleotide-capped mesoporous silica nanoparticles able to detect genomic DNA were designed.

DNA BacterialINGENIERIA DE LA CONSTRUCCIONDesignControlled-releaseSupportsOligonucleotidesNanoparticleNanotechnologyCatalysisLegionella pneumophilachemistry.chemical_compoundQUIMICA ORGANICAhemic and lymphatic diseasesCandida albicansBIOQUIMICA Y BIOLOGIA MOLECULARMaterials ChemistryMycoplasma fermentansColoring AgentsStimuliRhodaminesOligonucleotideChemistryQUIMICA INORGANICAMetals and AlloysGenomicsGeneral ChemistryMesoporous silicaSilicon DioxideControlled releaseDrug-deliverySurfaces Coatings and FilmsElectronic Optical and Magnetic Materialsgenomic DNADrug deliveryCeramics and CompositesNanoparticlesDNAChemical Communications
researchProduct

Selective, Highly Sensitive, and Rapid Detection of Genomic DNA by Using Gated Materials:MycoplasmaDetection

2013

The coupling of gated-indicator delivery with highly specific biochemical recognition is an innovative strategy for the detection of DNA sequences, able to compete with classical methods which need PCR amplification, in important areas such as point-of-care diagnostics or detection of specific biological contaminations with pathogens. Such comparatively simple and cheap yet highly selective and sensitive assays hold promise for use in less-developed areas of the world.

DNA BacterialINGENIERIA DE LA CONSTRUCCIONSupportsMesoporous silica nanoparticlesFermentansResponsive controlled releaseAmplificationmesoporous materialsBiologysensorsmedicine.disease_causeRapid detectionCatalysisgated materialschemistry.chemical_compoundMycoplasmaQUIMICA ORGANICAContaminationQUIMICA ANALITICABIOQUIMICA Y BIOLOGIA MOLECULARmedicineGated materialsRheumatoid arthritismycoplasmaControlled drug deliverySensorsQUIMICA INORGANICAGenomicsDNAGeneral ChemistryMycoplasmaCell culturesMolecular biologyHighly sensitivegenomic DNAchemistryDNAAngewandte Chemie International Edition
researchProduct

Impact of structural features of odorant molecules on their retention/release behaviours in dairy and pectin gels

2014

International audience; Reducing of fat content in food requires a reformulation that may cause a different perception of aroma. Maintaining an adequate level of acceptability of these reformulated products for consumers requires a better understanding of the mechanisms that control the retention of odorant molecules in food matrices. Although pectins are commonly employed as thickeners, their effect on the retention of odorant molecules in nonhomogeneous products has been examined more frequently than their effect on the retention of odorant molecules in simple gels models.The purpose of this study was to explore and compare the respective effects of pectin in simple model systems. The rel…

Dairy gelschemistry.chemical_classificationANOVAfood.ingredientOdorant moleculesPectinbiologyDouble bondFat contentAlcoholPrimary alcoholPectin gelsbiology.organism_classificationRetention/releasechemistry.chemical_compoundPairwise testsfoodchemistryNerolMoleculeOrganic chemistry[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biology[SDV.AEN]Life Sciences [q-bio]/Food and NutritionAromaFood ScienceFood Research International
researchProduct

Applications and Limitations of Dendrimers in Biomedicine

2020

Biomedicine represents one of the main study areas for dendrimers, which have proven to be valuable both in diagnostics and therapy, due to their capacity for improving solubility, absorption, bioavailability and targeted distribution. Molecular cytotoxicity constitutes a limiting characteristic, especially for cationic and higher-generation dendrimers. Antineoplastic research of dendrimers has been widely developed, and several types of poly(amidoamine) and poly(propylene imine) dendrimer complexes with doxorubicin, paclitaxel, imatinib, sunitinib, cisplatin, melphalan and methotrexate have shown an improvement in comparison with the drug molecule alone. The anti-inflammatory therapy focus…

Diagnostic ImagingDrugtargeted releasemedia_common.quotation_subjectAnti-Inflammatory AgentsBiomedical TechnologyPharmaceutical ScienceDiflunisalContext (language use)02 engineering and technologyReview010402 general chemistryPiroxicam01 natural sciencesimagining diagnosticsAnalytical Chemistrydendrimerslcsh:QD241-441lcsh:Organic chemistryDendrimerToxicity TestsDrug DiscoverymedicineAnimalsHumansDistribution (pharmacology)DoxorubicinPhysical and Theoretical Chemistrymedia_commonCell DeathChemistryOrganic Chemistry021001 nanoscience & nanotechnologyIbuprofenCombinatorial chemistry0104 chemical sciencesdrug therapyChemistry (miscellaneous)Molecular Medicinecytotoxicity0210 nano-technologymedicine.drugMolecules
researchProduct

Halloysite nanotubes for efficient loading, stabilization and controlled release of insulin

2018

Hypothesis: Oral insulin administration is not actually effective due to insulin rapid degradation, inactivation and digestion by proteolytic enzymes which results in low bioavailability. Moreover insulin is poorly permeable and lack of lipophilicity. These limits can be overcome by the loading of protein in some nanostructured carrier such as halloysite nanotubes (HNTs). Experiments: Herein we propose an easy strategy to obtain HNT hybrid materials for the delivery of insulin. We report a detailed description on the thermal behavior and stability of insulin loaded and released from the HNTs hybrid by the combination of several techniques. Findings: Release experiments of insulin from the H…

Dichroismmedicine.medical_treatmentHalloysite nanotube02 engineering and technology01 natural sciencesBiochemistryNanocompositesChitosanchemistry.chemical_compoundColloid and Surface ChemistryDrug StabilityProtein stabilityHalloysite nanotube (HNTs)InsulinTransdermalSettore CHIM/02 - Chimica FisicaDrug CarriersNanotubesProteolytic enzymes021001 nanoscience & nanotechnologyControlled releaseSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsEnzyme inhibitionAluminum SilicatesBionanocomposite film0210 nano-technologyHybrid materialBionanocomposite hybridSurface PropertiesDrug Compoundingengineering.materialCircular dichroism data010402 general chemistrySustained release InsulinAdministration CutaneousHalloysiteBiomaterialsKaolinitemedicineParticle SizeHybrid materialChitosanInsulinBiomedical applicationMedical applicationYarn Bio-nanocompositeMembranes Artificial0104 chemical sciencesNanotubeDrug LiberationHalloysite nanotubes Insulin Protein stability Sustained release Bionanocomposite hybridchemistryChemical engineeringDelayed-Action PreparationsengineeringClayNanocarriersSustained release
researchProduct

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levetiracetam.

2015

Literature and experimental data relevant for the decision to allow a waiver of in vivo bioequivalence (BE) testing for the approval of immediate release (IR) solid oral dosage forms containing levetiracetam are reviewed. Data on solubility and permeability suggest that levetiracetam belongs to class I of the biopharmaceutical classification system (BCS). Levetiracetam's therapeutic use, its wide therapeutic index, and its favorable pharmacokinetic properties make levetiracetam a valid candidate for the BCS-based biowaiver approach. Further, no BE studies with levetiracetam IR formulations in which the test formulation failed to show BE with the comparator have been reported in the open lit…

Dosage FormsSolid oral dosage formLevetiracetamChemistryChemistry PharmaceuticalPharmaceutical ScienceBiological AvailabilityPharmacologyBioequivalencePiracetamDosage formPermeabilityBiopharmaceuticsReference productBiopharmaceuticalTherapeutic EquivalencymedicineAnimalsHumansAnticonvulsantsLevetiracetamImmediate releasemedicine.drugJournal of pharmaceutical sciences
researchProduct

Mesoporous inorganic nanoscale particles for drug adsorption and controlled release.

2018

The review provides an overview of the mesoporous inorganic particles employed as drug delivery systems for controlled and sustained release of drugs. We have classified promising nanomaterials for drug delivery on the basis of their natural or synthetic origin. Nanoclays are available in different morphologies (nanotubes, nanoplates and nanofibers) and they are typically available at low cost from natural resources. The surface chemistry of nanoclays is versatile for targeted modifications to control loading and release properties. Synthetic nanomaterials (imogolite, laponite and mesoporous silica) present the advantages of well-established purity and availability with size features that …

Drug CarriersMaterials sciencePharmaceutical ScienceNanoparticleImogoliteNanotechnology02 engineering and technologyMesoporous silica010402 general chemistry021001 nanoscience & nanotechnologySilicon Dioxide01 natural sciencesControlled release0104 chemical sciencesNanomaterialsNanofiberDelayed-Action PreparationsDrug deliveryClayHumansNanoparticlesAdsorption0210 nano-technologyMesoporous materialPorosityTherapeutic delivery
researchProduct